Flow Cytometry
Monitors therapy cell phenotypes but lacks sensitivity beyond 1 in 10,000 cells and is applicable only for a short window post infusion.
Detect, isolate, and profile the rarest cells in the human body
Monitors therapy cell phenotypes but lacks sensitivity beyond 1 in 10,000 cells and is applicable only for a short window post infusion.
PCR is more sensitive than flow in detection of therapy cells post infusion but lacks insight into cell function and phenotypes.
Every individual therapy cell comprehensively profiled with high detection sensitivity.
Consult with an Expert
A blood-based assay for precise monitoring of persistence and function of therapeutic cells post infusion
Blood-based multiple myeloma risk stratification and therapy selection
Benchtop rare-cell detection and isolation platform to democratize precision medicine
An AI-driven photonic semiconductor platform for rare-cell detection, isolation, and characterization across large biological populations—
from discovery to clinical application.
At CellsBin®, we uncover the rare cells that shape human health and translate those insights into smarter decisions, earlier intervention, and better outcomes.
Our mission is to make rare-cell biology accessible at scale—so it becomes as essential to medicine as DNA sequencing is today.
Ready to revolutionize your rare cell detection capabilities?